Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Life Sciences Compliance: How to Stay Ahead of Regulatory Changes

Jun 21, 2025

Understanding the Importance of Compliance in Life Sciences

In the rapidly evolving landscape of life sciences, staying compliant with regulatory standards is critical for success and sustainability. Compliance ensures that companies not only adhere to legal requirements but also maintain trust with stakeholders, including patients, healthcare providers, and regulatory bodies. With regulations constantly changing, businesses must remain vigilant and proactive to avoid potential penalties and reputational damage.

Life sciences companies face unique challenges as they navigate a web of complex regulations that govern everything from clinical trials to marketing practices. These regulations are designed to protect public health and safety, making it essential for companies to stay ahead of changes and adapt their practices accordingly.

life sciences laboratory

Keeping Up with Regulatory Changes

The regulatory environment is dynamic, with frequent updates and amendments. To effectively manage compliance, companies should establish a robust system for tracking regulatory changes. This can be achieved by subscribing to industry newsletters, attending relevant conferences, and participating in professional forums. Regularly consulting with legal experts who specialize in life sciences can also provide valuable insights into upcoming regulatory shifts.

Additionally, leveraging technology can streamline the process of staying informed. Automated tools and software platforms designed for compliance management can help organizations efficiently monitor changes and ensure timely updates to policies and procedures.

Building a Culture of Compliance

Fostering a culture of compliance within an organization is crucial for long-term success. This involves training employees at all levels to understand the importance of compliance and their role in maintaining it. Regular workshops and training sessions can reinforce the company's commitment to ethical practices and regulatory adherence.

corporate training

Moreover, establishing clear communication channels for reporting compliance concerns can empower employees to voice their observations without fear of retribution. Encouraging an open dialogue about compliance not only helps identify potential issues early but also promotes a sense of responsibility among staff members.

Implementing Effective Compliance Strategies

An effective compliance strategy should be comprehensive yet flexible enough to adapt to changes. Start by conducting a thorough risk assessment to identify areas where non-compliance could pose significant risks. Based on this assessment, develop policies and procedures that address these vulnerabilities while ensuring alignment with current regulations.

Regular audits and reviews are essential components of an effective compliance strategy. These activities help identify gaps in compliance and provide opportunities for continuous improvement. By maintaining a proactive approach, companies can quickly adjust their strategies to align with new regulatory requirements.

compliance strategy

The Role of Leadership in Compliance

Leadership plays a pivotal role in driving compliance efforts across an organization. Executives should lead by example, demonstrating a strong commitment to ethical practices and regulatory adherence. By prioritizing compliance in decision-making processes, leaders can set the tone for the entire organization.

Involve leadership in compliance training and discussions to ensure they are informed about the latest regulatory changes and their implications. This top-down approach reinforces the importance of compliance at every level of the organization.

Conclusion

Staying ahead of regulatory changes in the life sciences sector requires vigilance, adaptability, and a strong commitment to compliance. By keeping informed, fostering a culture of compliance, implementing effective strategies, and engaging leadership, companies can navigate the complexities of regulation while maintaining their reputation and competitive edge.

Ultimately, embracing compliance as an integral part of your business strategy will not only protect your organization but also contribute to the advancement of safe and effective life sciences innovations.